West Pharmaceutical Services, Inc [NYSE: WST] traded at a high on 2025-08-29, posting a 0.61 gain after which it closed the day’ session at $246.95.
The results of the trading session contributed to over 462980 shares changing hands. Over the past one week, the price volatility of West Pharmaceutical Services, Inc stands at 1.72% while the volatility over the past one month is 2.05%.
The market cap for WST stock reached $17.76 billion, with 71.90 million shares outstanding and 71.46 million shares in the current float. Compared to the average trading volume of 693.61K shares, WST reached a trading volume of 462980 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about West Pharmaceutical Services, Inc [WST]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for WST shares is $314.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on WST stock is a recommendation set at 1.59. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for West Pharmaceutical Services, Inc shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on June 24, 2025. While these analysts kept the previous recommendation, Evercore ISI raised their target price to Outperform. The new note on the price target was released on March 18, 2025, representing the official price target for West Pharmaceutical Services, Inc stock. Previously, the target price had yet another raise to $250, while Deutsche Bank analysts kept a Buy rating on WST stock.
The Price to Book ratio for the last quarter was 6.06, with the Price to Cash per share for the same quarter was set at 7.09. Price to Free Cash Flow for WST in the course of the last twelve months was 51.62 with Quick ratio for the last quarter at 2.08.
How has WST stock performed recently?
West Pharmaceutical Services, Inc [WST] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.36. With this latest performance, WST shares gained by 3.21% in over the last four-week period, additionally plugging by 6.29% over the last 6 months – not to mention a drop of -24.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for WST stock in for the last two-week period is set at 56.16, with the RSI for the last a single of trading hit 5.38, and the three-weeks RSI is set at 6.51 for West Pharmaceutical Services, Inc [WST]. The present Moving Average for the last 50 days of trading for this stock 234.70, while it was recorded at 246.02 for the last single week of trading, and 256.77 for the last 200 days.
West Pharmaceutical Services, Inc [WST]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and West Pharmaceutical Services, Inc [WST] shares currently have an operating margin of 21.12% and a Gross Margin at 35.32%. West Pharmaceutical Services, Inc’s Net Margin is presently recorded at 16.48%.
West Pharmaceutical Services, Inc (WST) Capital Structure & Debt Analysis
According to recent financial data for West Pharmaceutical Services, Inc. ( WST), the Return on Equity (ROE) stands at 17.72%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 13.11%, reflecting the company’s efficiency in generating profits from its assets. Additionally, West Pharmaceutical Services, Inc’s Return on Invested Capital (ROIC) is 15.17%, showcasing its effectiveness in deploying capital for earnings.
West Pharmaceutical Services, Inc (WST) Efficiency & Liquidity Metrics
Based on West Pharmaceutical Services, Inc’s (WST) latest financial statements, the Debt-to-Equity Ratio is 0.11%, indicating its reliance on debt financing relative to shareholder equity.
West Pharmaceutical Services, Inc (WST) Efficiency & Liquidity Metrics
From an operational efficiency perspective, West Pharmaceutical Services, Inc. (WST) effectively leverages its workforce, generating an average of $46009.43 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.78% and a Quick Ratio of 2.08%, indicating strong ability to cover short-term liabilities.
Earnings analysis for West Pharmaceutical Services, Inc [WST]
With the latest financial reports released by the company, West Pharmaceutical Services, Inc posted 1.85/share EPS, while the average EPS was predicted by analysts to be reported at 1.49/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.36. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for WST. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for West Pharmaceutical Services, Inc go to 7.86%.
Insider trade positions for West Pharmaceutical Services, Inc [WST]
There are presently around $98.25%, or 98.85%% of WST stock, in the hands of institutional investors. The top three institutional holders of WST stocks are: VANGUARD GROUP INC with ownership of 8.94 million shares, which is approximately 12.2519%. BLACKROCK INC., holding 7.58 million shares of the stock with an approximate value of $$2.5 billion in WST stocks shares; and BLACKROCK INC., currently with $$1.08 billion in WST stock with ownership which is approximately 4.4849%.
